Mylan N.V., makers of the anti-allergic reaction EpiPen, announced programs Thursday to lower the device's cost after U.S. senators expressed outrage at the price increase.
The single-use auto-injection pens, used as dispensers of the medicine epinephrine in emergencies resulting from food allergies, were created by Merck Group in the 1970s, and were acquired by Mylan in 2007. A price increase, from $57 per pen in 2007 to about $500 per pen today, drew the anger, earlier this week, of four U.S. senators who asked Mylan for an explanation.
EpiPen maker offers patients $300 savings cards
The world’s largest hornet, an invasive breed nicknamed the “murder hornet” for its dangerous sting and...
More than two months after Missouri residents voted to add abortion rights into their state constitution...
